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29Feeder/serum-free human embryonic stem cell cultureIntroduction
The most reliable and robust method used to maintain
pluripotent human embryonic stem (hES) cells in tissue
culture is by coculture on mitotically inactivated mouse
feeder cells (MEFs) (Thomson et al., 1998; Amit et al., 2000).
However, hES cells cultured under these conditions are
exposed to xenoantigens from the feeder cells and accumu-
late animal cell products including the sialic acid Neu5Gc
(Martin et al., 2005) and bovine apolipoprotein B-100
(Hisamatsu-Sakamoto et al., 2007). To get around the
potential zoonotic pathogen and xenoantigen problems, a
variety of human feeder cells including adult and fetal-
derived fibroblasts (Richards et al., 2002, 2003; Inzunza et
al., 2005) and autogenic fibroblasts derived from hES cells
(Stojkovic et al., 2005) have been used to support the
derivation and maintenance of hES cells (Richards et al.,
2002). However, the properties of primary feeder cells are
subject to donor to donor variation (Richards et al., 2003)
and the undefined factors they provide hamper experimental
analysis.
As an alternative to feeder cells, hES cells have been
cultured on either Matrigel (BD, Oxford, UK) (Yao et al.,
2006) or fetal bovine serum (Vallier et al., 2005). Although
human serum has also been used there is evidence that it
contains factors that can induce hES cell differentiation
during long-term culture (Richards et al., 2003; Rajala et al.,
2007). While such culture additives have been used with
some success, they are still poorly defined animal deriva-
tives; Matrigel is a mixture of animal basement membrane
components and growth factors extracted from the EHS
mouse sarcoma cell line (Kleinman et al., 1982), while sera
contain components including growth factors, extracellular
matrix molecules, and hormones, many of which are still
undefined. In 2004, Amit et al. described a serum-free
medium containing serum replacement that was supplemen-
ted with both FGF2 and TGFβ1. This medium was able to
support hES cells on a human fibronectin substrate (Amit et
al., 2004). However serum-replacement supplements are not
fully defined and have also resulted in spontaneous hES cell
differentiation (Xu et al., 2005).
Improved long-term hES cell maintenance has been
achieved using MEF conditioned medium (Xu et al., 2001)
or defined media that include growth factors produced by
MEFs (Chin et al., 2007; Lu et al., 2006). In 2006 Ludwig et
al. successfully derived two new hES cell lines using
completely defined culture conditions (“TeSR1” culture
medium on a human extracellular matrix substrate) but
both lines became karyotypically abnormal after extended
culture (Ludwig et al., 2006). It is likely that a hES cell line
derived under more stringent feeder-free, defined condi-
tions would be subject to increased selective pressure to
undergo karyotypic change on culture adaption (Baker et
al., 2007).
We describe here the validation of a fully defined,
feeder and serum-free culture system that supports the
extended self-renewal of pluripotent, karyotypically normal
multiple hES cell lines with minimal spontaneous differ-
entiation. The components of this system are derived from
a combination of previously published techniques (Vallier et
al., 2005; Liu et al., 2006) that individually are unable to
support the long-term self-renewal of some of the availablehES lines we are using. We demonstrate that it is necessary
to supplement defined medium with FGF2, activin A, and
neurotrophin 4 (NT4), and we analyze the roles of each of
these factors on hES cell behavior. Furthermore, we
demonstrate that human fibronectin acts specifically via
α5β1 integrin to support self-renewal. Thus, this study both
describes and analyses a potentially scalable culture system
for the maintenance of hES cells under fully defined
conditions.
Results
Growth of HUES7 hES cells under previously
described conditionsHUES7 hES cells were cultured on MEF layers in medium
containing KSR and passaged with trypsin approximately
every 7 days according to the HUES Cell Collection Instruc-
tion Manual (HUES Cell Collection Instruction Manual). On
feeders HUES7 cells formed distinct colonies that displayed
nuclear OCT4 immunostaining (Fig. 1a).
In order to assess hES cell growth factors and substrate
requirements for maintenance and expansion, it was
necessary to use more defined culture conditions without
feeders and KSR. We chose initially to compare the abilities
of previously published feeder/serum-free culture condi-
tions to support the self-renewal of HUES7 hES cells. We
examined the media described by Vallier et al., for H9 cells
(Vallier et al., 2005), and Lui et al., for H1 and H9 cells (Liu et
al., 2006). As our aim was to examine substrate–hES cell
interaction, we chose to culture hES cells on a defined human
plasma fibronectin substrate as described by Lui et al.,
rather than Matrigel, as described by Vallier et al., which is a
composite substrate that includes undefined murine
components.
Compared to culture on feeder cells, after 10 days culture
(2 passages, cells split 1:1), few cells remained in both
feeder-free systems. These did not exhibit typical hES cell
morphology. . More importantly, the cells under both feeder-
free conditions had started to differentiate as determined by
the absence of OCT4 immunostaining (Figs. 1b, c). Thus,
while the MEF feeder cells were able to support the self-
renewal of HUES7 cells, the previously described feeder cell-
free conditions (Vallier et al., 2005; Liu et al., 2006) failed to
maintain their self-renewal.
Derivation of modified culture conditions
In order to modify and optimise a serum-free medium to
support HUES7 cell self-renewal and to allow the investiga-
tion of hES cell growth factor requirements, we supplemen-
ted the medium described by Liu et al. (2006) with activin A
(10 ng/ml) as described by Vallier et al. (2005). With the
addition of activin A more cells survived over a longer period
in culture (3 passages over 2 weeks) but the majority were
OCT4-, Nanog-; indicating that they had begun to differ-
entiate (Figs. 2a–c). Given that neurotrophin 4 (NT4) has
been previously shown to promote H1 and H9 hES cell survival
(Pyle et al., 2006), we therefore added 4 ng/ml NT4 to the
combined culture medium. With the addition of NT4 hES cell
Figure 1 HUES7 cells cultured under different culture conditions: on fibronectin on MEF cells (a), under conditions described by
Vallier et al., (b) and Lui et al., (c) and under our modified culture conditions; with a ×10 magnified inset of DAPI, OCT4, and merged
channels (d). Immunostained for OCT4. Scale bars 100 μm.
30 M.A. Baxter et al.survival increased as expected, cultures expanded rapidly
(Figs. 2m, n), and importantly the majority remained OCT4+
and Nanog+ for 3 passages over 2 weeks (Figs. 1d, 2d–f).
Therefore the combination of FGF2 and activin A, together
with NT4 supplementation (Pyle et al., 2006) is necessary for
the long-term maintenance of HUES7 cells under serum- and
MEF-free conditions.
To establish the necessity and role of FGF2 and activin A in
the presence of NT4, HUES7 were cultured for 3 passages
over 2 weeks with NT4 but without either FGF2 or activin A.
In the absence of activin A, HUES7 cells lost both OCT4 and
Nanog expression, cultures adopted a heterogeneous mor-
phology, and growth rates significantly decreased (Figs. 2g–i,
m). Interestingly, the removal of activin A had no affect on
cell survival (Fig. 2n). In the absence of FGF2 cultures also
adopted a heterogeneous morphology with loss of OCT4 and
Nanog expression and decreased cell survival (Figs. 2j–l).
Most strikingly, the rate of culture expansion significantly
decreased, indicating an important role in proliferation (Fig.
2n). Taken together, these results confirm that FGF2, activin
A, and NT4 are all essential for hES cell self-renewal under
these serum/feeder-free culture conditions.
Validation of modified feeder/serum-free
culture conditions
HUES7 hES cell feeder cultures were dissociated using
trypsin and seeded at a plating efficiency of 84±3% (n=4)
onto fibronectin in the serum-free medium. This indicated
that the majority of hES cells had survived from the feeder
culture on the fibronectin substrate. Long-term culture
demonstrated that these conditions supported the self-
renewal of HUES7 cells for N10 passages cells were culturedup to 15 passages for N3 months continuous culture. The
conditions were also able to support the long-term self-
renewal of MAN1 and HUES1 hES cells for N10 passages
(Supplemental Fig. 1). All 3 hES cell lines cultured under
these conditions were successfully cryopreserved and
reestablished after thawing (not shown). Morphologically
all hES cell lines exhibited a typical hES cell phenotype with
a high nucleus to cytoplasmic ratio and prominent nucleoli
(Supplemental Figs. 1a–d). Throughout culture all hES cell
lines remained OCT4+, Nanog+, TRA1-60+, TRA1-81+, SSEA3+,
and SSEA4+ as demonstrated by immunostaining. FACS
analysis showed that after 10 passages 97.9% HUES7 and
93.6% HUES1 cells were Nanog+ (Figs. 3a–d) and 93.0%
HUES7 and 86.4% HUES1 cells were OCT4+ (Figs. 3e–h).
Furthermore, the HUES7 cells exhibited no expression of
CD30, a biomarker of transformed human pluripotent stem
cells (Herszfeld et al., 2006) (Supplemental Fig. 2). More-
over, karyotypic analysis of hES cells cultured for 10 passages
under these conditions exhibited a normal, diploid karyo-
type (Supplemental Fig. 3) with the appearance of only few
sporadic abnormalities (a deletion of 16q and a deletion of
18q have been detected).
hES cell differentiation after long-term culture
under modified conditions
To demonstrate the maintenance of differentiative capacity,
embryoid bodies were formed by suspension culture of
HUES7, MAN1, and HUES1 after culture for N10 passages in
the serum/feeder-free system. By Day 1, cell suspensions
had formed small cell clusters, which became more regular
and compact by Day 2 (Supplemental Fig. 4). By Day 4 the
embryoid bodies appeared to have formed a distinct
Figure 2 HUES7 cells cultured in the absence of either NT4 (a–c), under the complete feeder/serum-free conditions (d–f), in
the absence of activin A (g–i), or in the absence of FGF2 (j–l) for 3 passages for over 2 weeks. Cells were then immunostained for
OCT4 (b, e, h, k) and Nanog (c, f, i, l). Scale bars 50 μm. (m) HUES7 culture kinetics determined over 11 days under complete
feeder/serum-free conditions with either all growth factors or in the absence of each growth factor (n=3). (l) The percentage of cell
death determined at 11 days (3 passages), a significant difference in comparison to the control is indicated (n=3, Pb0.05).
31Feeder/serum-free human embryonic stem cell cultureperipheral layer reminiscent of the endodermal cell layer of
mouse embryoid bodies (Murray and Edgar, 2004) when
observed by phase contrast microscopy. By Day 13, the
peripheral layer appeared thicker and the inner core more
compact. Day 13 embryoid bodies derived from HUES7 cells
were cryosectioned and immunostained. The embryoid
bodies were OCT4- and exhibited peripheral AFP+ cells
surrounding a laminin-positive ring of apparent basementmembrane (Supplemental Figs. 4g–i). To confirm hES cell
pluripotency, Day 13 embryoid bodies (EBs) were plated onto
serum-coated glass coverslips and cultured for 2 weeks in
serum-containing medium. The differentiating cells from all
hES cell lines demonstrated positive immunostaining for
ectoderm markers including neurofilament, βIII-tubulin, and
GFAP; mesoderm markers brachyury and vimentin and
endoderm markers including neurogenin 3, FOXA2, and AFP
Figure 3 FACS analysis of HUES7 (a, b, e, f) and HUES1 (c, d, g, h) cells after culture for 10 passages under defined feeder-free
conditions; Nanog secondary only control (a, c) and Nanog (b, d), OCT4 secondary only control (e, g) and OCT4 (f, h).
32 M.A. Baxter et al.(see Fig. 4 and Supplemental Fig. 5). This shows that HUES7,
HUES1, and MAN1 hES cell lines remain pluripotent following
long-term culture in this feeder/serum-free system.
RT-PCR using human-specific primers was carried out on
cDNA from HUES7 cultured with and without feeders for 10Figure 4 Day 7 embryoid body outgrowths generated from HU
conditions. Outgrowths were immunostained for neurofilaments (a),
(d), brachyury (e), and AFP (f). Scale bars 50 μm. Expression of differ
from HUES7 culturedN10 passages under feeder/serum-free cond
passages under feeder/serum-free conditions: negative control (4) a
cDNA (7) and human genomic DNA (8).passages, and Day 7 embryoid bodies generated from passage
10, feeder-free HUES7 cultures (Fig. 4). OCT4 was expressed
in both types of hES cell culture and by embryoid bodies. By
Day 7, embryoid bodies generated from feeder-free HUES7
cultures expressed mesoderm markers FLK1, brachyury, andES7 cultured for N10 passages under the feeder/serum-free
vimentin (b), glial fibrillary-associated protein (c), neurogenin 3
entiation markers (h). Water blank (1); embryoid bodies derived
itions: negative control (2) and cDNA (3); HUES7 culturedN10
nd cDNA (5); HUES7 cultured on feeders: negative control (6) and
33Feeder/serum-free human embryonic stem cell cultureMIXL1; endoderm markers AFP, GATA4,and SOX17; and
ectoderm markers nestin, SOX1, and PAX6. Expression of all
these markers other than nestin and AFP was absent in the
undifferentiated feeder-free HUES7 cultures. However,
HUES7 harvested after culture on feeders expressed detect-
able SOX17, GATA4, MIXL1, and brachyury as well as AFP and
nestin. As all the primers were human specific (Supplemental
Fig. 6); this suggested that a higher level of background
differentiation can occur when HUES7 are grown on feeders 5
days after seeding in comparison to the feeder-free system,
in which N95% of HUES7 are OCT4 and Nanog positive (Fig. 3).
Taken together, these observations demonstrate that hES
cells remain pluripotent but retain differentiative capacity
following long-term culture in this feeder-free system.
Role of FGF2 in defined culture medium
It has been previously reported that FGF2 supports hES cell
culture indirectly by stimulating the production of other
supportive factors such as IGFII and TGF-β family membersFigure 5 HUES7 cells cultured with IGFII (a, c, e) or FGF2 (b, d,
f, g) under the feeder/serum-free conditions: immunostained for
OCT4 (c, d) and Nanog (e, f) or costained for both Nanog (green)
and FGFR1 (red) (g). Growth kinetics of cultures over 11 days (up
to 4 passages) in the presence of either IGFII or FGF2 (h). Scale
bars 50 μm.
Figure 6 HUES7 cells cultured on either laminin (b, d, e) or
fibronectin (a) in the serum-free medium: growth kinetics over 3
passages (c), a significant difference between the two data sets
is indicated (n=3, Pb0.05). HUES7 after culture on laminin for 3
passages immunostained for Nanog (d) and OCT4 (e). Scale bars
50 μm.from fibroblast-like cells generated by hES cells in culture
(Bendall et al., 2007). In light of this, we sought to determine
whether IGFII could support hES cell culture in the absence of
exogenous FGF2 under our more defined feeder/serum-free
culture conditions. HUES7 cells were grown for 4 passages
over 11 days with the addition of either IGFII or FGF2. In our
system, after 4 passages with IGFII cultures appeared
morphologically heterogeneous, with small OCT4+, Nanog+
colonies surrounded by OCT4-, Nanog- fibroblastic-like cells
(Fig. 5). In contrast, in the presence of FGF2 cultures
exhibited homogeneous hES cell morphology and the
majority of cells were OCT4+, Nanog+. Culture growth rate
was also slower in the presence of IGFII compared to FGF2
(Fig. 5h). It has also been reported that pluripotent hES cells
do not express the FGFR1 receptor; and therefore FGF2 does
not act directly on hES cells (Bendall et al., 2007). However,
immunostaining of HUES7 under our culture conditions
clearly showed a colocalisation of FGFR1 on many Nanog+
cells (Fig. 5g). Together, our results show that in the absence
of exogenous FGF2 the addition of IGFII allows the develop-
ment of a subpopulation of differentiating cells. With the
addition of FGF2 in the absence of exogenous IGFII this
differentiating subpopulation is absent. Therefore for the
maintenance of hES cell cultures the addition of IGFII cannot
substitute for the addition of FGF2 under these feeder/
serum-free culture conditions.
34 M.A. Baxter et al.Role of fibronectin substrates with defined
culture medium
To investigate the requirement of hES cell self-renewal on
fibronectin substrates, HUES7 cells were cultured for 3
passages on either human placenta laminin or fibronectin in
the defined medium. We found no significant difference
between the plating efficiency on laminin compared to that
on fibronectin (96±1% versus 98±1%, respectively, PN0.05).
On fibronectin, hES cells exhibited typical hES cell
morphology, a high ratio of nucleus to cytoplasm and
prominent nucleoli (Fig. 6a). In contrast, on laminin hES
cell colonies were more compact and peripheral cells
exhibited multiple processes (Fig. 6b) that were absent on
fibronectin. After 3 passages on laminin, the majority of
cells still remained Nanog+, OCT4+ (Figs. 6d, e), but the
growth rate was significantly slower on laminin compared
to that on fibronectin (Fig. 6c). These data show that while
both fibronectin and laminin can support hES cell self-Figure 7 HUES7 coimmunostained for α5 integrin (red), OCT4
counterstaining (a); β1 integrin (green), OCT4 (red), inset, β1 integri
integrin (red), Nanog (green), inset, active β1 integrin (red) with DAP
αV integrin isotype control (red) with DAPI counterstaining (d). Scale
antibody (e), α5 integrin antibody (f), αV integrin antibody (g), and
(n=3, Pb0.05).renewal, hES cells exhibit a higher proliferative rate on
fibronectin.
To investigate the mechanism of interaction between hES
cells and the fibronectin substrate, cells cultured under
feeder-free conditions on fibronectin were immunostained
with antibodies for α5, αV, and β1 integrin. OCT4+ hES cells
cultured for N5 passages on fibronectin expressed α5 and β1
integrin receptors (Figs. 7a, b). In addition, Nanog+ hES cells
also exhibited active β1 integrin, as determined by costain-
ing with antibody specific to the active form of β1 (Fig. 7c).
Immunostaining indicated that Nanog+ hES cells also
expressed αV integrin, although the antibody signal was
low (Fig. 7d).
The addition of anti-β1 antibody inhibited cell attach-
ment to fibronectin in a dose-dependent manner. The
amount of 10 μg/ml anti-β1 blocked all cell attachment
whereas after 4 h 85±1% (n=3) of hES cells had attached in
the presence of 10 μg/ml isotype control antibody (Fig. 7e).
These data suggest that functional β1 integrin is necessary(green), inset, α5 integrin isotype control (red) with DAPI
n isotype control (green) with DAPI counterstaining (b); active β1
I counterstaining (c) and αV integrin (red), Nanog (green), inset,
bars 15 μm. HUES7 adhesion to fibronectin with anti-β1 integrin
RGD peptide (h), a significant difference to the control is shown
35Feeder/serum-free human embryonic stem cell culturefor the attachment of hES cells to fibronectin. Interestingly,
after 24 h HUES7 cultures treated with 10 μg/ml anti-β1
antibody still showed no attachment to the fibronectin;
instead cells had clustered into balls resembling early EBs
(Supplemental Fig. 7). Addition of anti-α5 integrin reduced
cell adhesion in a dose-dependent manner, although only by
46±3% (n=3, Pb0.001) at 50 μg/ml (Fig. 7f). In contrast the
addition of anti-αV blocking antibody did not inhibit hES cell
adhesion to fibronectin (Fig. 7g). To determine whether the
α5 or β1 integrin receptors were interacting with the
fibronectin substrate via the RGD tripeptide motif, soluble
peptide encoding RGD was added to the culture system. This
blocked hES cell adhesion in a dose-dependent manner:
1 mg/ml blocked 54±7% cell adhesion in comparison to only
14±2% in the presence of 1 mg/ml control peptide (n=3,
P=0.006, Fig. 7h).Discussion
We have used a refined hES cell culture system to examine
the individual roles of both growth factors and extracellular
matrix molecules in self-renewal and maintenance of
pluripotency. Previously published defined, serum/feeder-
free culture conditions for the long-term maintenance of
pluripotent hES cells have proved difficult to reproduce
(Rajala et al., 2007). This may at least be partly explained by
the fact that they have often been validated using particular
hES cell lines and so may not necessarily be appropriate for
all. Indeed we found that two previously published methods
(Vallier et al., 2005; Liu et al., 2006) were insufficient to
support the commonly used HUES7 hES cell line. However,
based on both of these methods we delineate a feeder-free
culture system that can support the self-renewal of at least 3
different hES cell lines; HUES7, HUES1, and MAN1.
Under previously reported feeder-free conditions there is
evidence that hES cells adapt by differentiating to produce a
subpopulation of autologous feeders which may be able to
provide the supportive factors necessary to maintain hES cell
self-renewal (Bendall et al., 2007). Alternatively a subpopula-
tion of hES cells may themselves adapt to survive under
suboptimal culture conditions (Baker et al., 2007). However,
the plating efficiency of the hES cell lines when transferred to
the present conditions was high (N80%), indicating that there
is no apparent selection of a hES cell subpopulation.
Furthermore, we did not detect the presence of a feeder
cell subpopulation as flow cytometry showed that N95% of
cells were OCT4 and Nanog positive. Morphologically, cultures
were homogeneous with cells presenting a typical hES cell
appearance. RT-PCR also demonstrated the lack of various
differentiation marker expressions that were often present
when hES cells were cultured on MEF layers. These data
suggest that this system can reduce the background differ-
entiation sometimes present in conventional MEF cell cocul-
tures, possibly due to heterogeneity in the microenvironment
provided by the MEF cells. It also indicates that our feeder/
serum-free culture system provides all the growth factors
necessary to maintain long-term hES cell self-renewal.
Our results clearly show that all three growth factor
supplements are necessary for long-term hES cell mainte-
nance, and has allowed a better understanding of each of
their roles in pluripotency or self-renewal. It has previouslybeen reported that activin A can inhibit hES cell differentia-
tion by activation of SMAD 2/3 signaling (James et al., 2005;
Peerani et al., 2007; Pera et al., 2004; Xu et al., 2002).
Indeed, we found that in the absence of activin A, hES cells
lost pluripotency by 3 passages as shown by a loss of OCT4
and Nanog expression, in addition to a reduction in the rate
of hES cell proliferation. Similarly, it has been previously
shown that NT4 promotes hES cell survival on MEFs or
Matrigel (Pyle et al., 2006) and we demonstrate here that the
absence of NT4 reduced cell survival over 3 passages. In the
absence of NT4 hES cells lost Nanog and most OCT4
expression, indicating either the selection of differentiated
cells due to reduced hES cell survival or an additional role of
NT4 in the maintenance of hES cell pluripotency.
Most media for hES cell culture, both on and off feeder
cells, are supplemented with FGF2 (Amit et al., 2004). FGF2
may maintain pluripotency by activation of the MEK/ERK and
PI3K/AKT signaling cascades (Li et al., 2007) and inhibit
differentiation by the suppression of SMAD1 signaling
(Peerani et al., 2007). Consistent with this, under our
feeder/serum-free culture conditions the withdrawal of
FGF2 led to a loss of both Nanog and OCT4 expression. In
addition there was decreased cell survival after 3 passages,
preceded by a significant reduction in culture growth rate
that became noticeable as early as 3 days after FGF2
withdrawal.
It has recently been suggested that FGF2 supports hES cell
culture indirectly by stimulating hES cell-derived fibroblast-
like cells to produce hES cell-supportive factors such as IGFII
and TGFβ family members (Bendall et al., 2007). However
we found that in the absence of exogenous FGF2, the
addition of IGFII facilitated hES cell differentiation, leading
to the generation of an OCT4-, Nanog- subpopulation of cells
that surrounded hES cell colonies. In contrast, in the
presence of FGF2 this subpopulation of fibroblast-like cells
was not observed. Furthermore the presence of FGFR1 on
Nanog+ hES cells (Fig. 5g) suggested that FGF2 can act
directly on these cells. This has also been reported by
Schuldiner et al. (2000). Our data therefore suggest that
FGF2 does not maintain hES cell self-renewal via the
stimulation of factors from a subpopulation of fibroblast-
like cells under our conditions. The discrepancies between
our observations and those of Bendall et al. are likely to
result from different culture conditions: the substrate used
in our study was purified human plasma fibronectin, whereas
previously mouse Matrigel was used (Bendall et al., 2007).
Matrigel contains a variety of different biologically active
factors (Kleinman et al., 1982), any of which may induce
background differentiation that might explain the observa-
tion of a differentiated subpopulation (Bendall et al., 2007).
This highlights the importance of developing more defined
culture conditions to allow clearer interpretation of hES cell
responses.
Our results demonstrate the requirement for appropriate
human extracellular matrix substrate for hES cell self-
renewal in the absence of serum and feeder cells. As laminin
has been reported to support pluripotent hES cell culture we
compared human plasma fibronectin with human placenta
laminin. We found that while fibronectin and laminin could
both support self-renewal, hES cell culture growth was faster
on fibronectin. These data suggest that human plasma
fibronectin may be a better substrate for hES cell
36 M.A. Baxter et al.maintenance, in terms of proliferation rates, lack of
spontaneous differentiation, and scalability in comparison
to human placenta laminin. The fact that both could support
hES cell culture to some extent indicates some redundancy in
the ability of ECM protein substrates to support hES cell self-
renewal. Indeed vitronectin has also been shown to maintain
hES cell self-renewal (Braam et al., 2008), albeit with some
spontaneous differentiation necessitating mechanical dis-
sociation to allow the removal of differentiated cells.
Although we have not examined whether vitronectin could
support hES cell culture with our medium, Lui et al. have
reported that with their medium (which includes 100 ng/ml
FGF2, the N2 and B27 supplements but no activin A or NT4)
vitronectin could not support hES cell for 7 days (Liu et al.,
2006).
The mechanism by which hES cells interact with and are
maintained by such substrates has been little investigated
and here we start to decipher some of the key cellular
receptors. The α5β1 integrin is a major receptor for
fibronectin (Hayashi et al., 2007) and under the feeder/
serum-free conditions hES cells expressed both the α5 and
the active β1 integrin receptor subunits, as previously shown
when cultured on feeder cells (Braam et al., 2008).
Importantly, a functional role of the integrin could be
demonstrated by inhibition of hES cell attachment to
fibronectin substrates with an RGD peptide and with blocking
antibodies to either of the integrin subunits. In contrast to
total inhibition with β1 antibodies, there was only a partial
inhibition with anti-α5, consistent with the existence of
alternative integrin α subunits that can bind fibronectin.
Indeed the αV subunit normally present on mES cells has
been shown to functionally compensate for the loss of the α5
subunit in α5 null mES cells plated on fibronectin (Yang and
Hynes, 1996). However, we found no inhibition of cell
attachment to fibronectin with anti-αV blocking antibody.
The addition of soluble RGD peptide blocked some but not all
adhesion, suggesting that alternative fibronectin binding
sites might also mediate hES cell adhesion to fibronectin
(Mostafavi-Pour et al., 2001). These data are consistent with
the recent observation that the αVβ5 integrin functions as a
receptor for vitronectin substrates (Braam et al., 2008).
However, the αV subunit does not appear to be involved with
hES cell/fibronectin interactions, and so other α subunits
(for example, α4) may be involved. Interestingly, cell to cell
adhesion appeared unaffected by blocking anti-β1 integrin
antibody (since the nonattached cells were able to aggre-
gate). Similarly previous reports showed that β1 integrin-
deficient mES cells also do not exhibit impaired cell to cell
adhesion and are able to integrate normally into the inner
cell mass (Fassler et al., 1995). It is well recognised that cell
behavior is regulated by the cross-talk between signaling
pathways dependent on integrin-mediated cell adhesion and
growth factors (Schwartz and Ginsberg, 2002). Future work
will analyse such cross-talk in the hES cells leading to their
self-renewal.
The feeder/serum-free culture conditions described here
already exploit this cross-talk to provide a defined system for
investigation into hES cell-ECM interactions, which result in
the elimination of essentially all hES cell spontaneous
differentiation. This work therefore represents an important
advance in understanding the role of soluble growth factors
and substrate-bound components in hES cell maintenance.Materials and methods
Human ES cells
Cleavage stage embryos were donated after informed
consent by couples undergoing IVF treatments at St. Mary's
Hospital. Embryos were cultured to blastocyst stage in G3
series sequential media (Vitrolife, Edinburgh, UK). At
blastocyst stage, the zona pellucida was removed by
treatment with acid Tyrode's solution (Sigma), and denuded
blastocysts were washed in G2 media (Vitrolife). The
trophectoderm (TE) was partially removed mechanically
and the inner cell mass seeded onto MEFs. This was cultured
for 8 days and then the outgrowth was passaged by manual
dissection for the initial 10 passages (MAN1). HUES1 and 7
were obtained from Harvard University (hES Cell Facility/
Melton Laboratory, MA, USA).
hES cell culture on feeder cells
Murine embryonic fibroblast feeder cells (MEFs) were
prepared from Day 13.5 CD1 mouse embryos, cultured in F-
DMEM (DMEM (Lonza, Nottingham, UK) supplemented with
10% fetal bovine serum (FBS), 2 mM L-glutamine, and
1×penicillin/streptomycin (Invitrogen, Paisley, UK), and
mitotically inactivated at passage 3–5 with 10 μg/ml
mitomycin C (Sigma, Dorset, UK). The hES cells lines
HUES7, HUES1, and MAN1 were cultured on MEFs plated at
a density of 6× 104 cm-2 on 0.1% gelatin (Sigma)-coated
dishes 24 h previously. The hES cells were cultured on MEFs in
knockout Dulbecco's modified Eagle's medium (DMEM) sup-
plemented with 20% (v/v) knockout serum replacement
(KSR), 2 mM L-glutamine, 1% (v/v) nonessential amino acids
(NEAA), 0.1 mM β-mercaptoethanol, 1% (v/v) penicillin/
streptomycin (all Invitrogen) and 10 ng/ml FGF2 (Autogen
Bioclear, Wiltshire, UK). They were passaged using 0.25% (w/
v) trypsin/1 mM EDTA (Invitrogen) as previously described
(Ellerstrom et al., 2007).
Feeder-free hES cell culture
The hES cells were initially cultured in either the serum-free
culturemedium previously described by Lui et al. (DMEM/F12,
N-2 and B-27 supplements, 1 mM L-glutamine, 1% NEAA,
0.1 mM β-mercaptoethanol, and 100 ng/ml bFGF (Invitrogen)
(Liu et al., 2006) or the serum-free medium previously
described by Vallier et al. (50:50 IMDM:F12 NUT MIX (Invitro-
gen), 7 μg/ml insulin, 15 μg/ml transferrin (Roche, Welwyn
Garden City, UK), 0.45 mMmonothioglycerol, 5 mg/ml bovine
serumalbumin factor V (Sigma), 10 ng/ml activin (Preprotech,
London, UK), and 12 ng/ml FGF2 (Vallier et al., 2005).
Subsequently, for our feeder/serum-free culture conditions,
hES cells were cultured in 50:50 F12:DMEM (Lonza) supple-
mented with 2 mM L-glutamine, 1% NEAA, 0.1 mM β-
mercaptoethanol, 1% penicillin/streptomycin, 0.1% bovine
serum albumin (BSA) (Sigma), N2 supplement (consisting of
10 g/L transferrin, 500mg/L insulin, 0.63 mg/L progesterone,
1.611 g/L putrescine), B27 supplement (components
described by Brewer et al. (Brewer et al., 1993); concentra-
tion of components are not publicly disclosed) (both from
Invitrogen), 10 ng/ml activin A, 4 ng/ml neurotrophin 4
37Feeder/serum-free human embryonic stem cell culture(Preprotech, London, UK), and 40 ng/ml FGF2 on 3.5-, 6-, or
10-cm plates coated overnight with a 50 μg/ml human plasma
fibronectin (Millipore, Hertfordshire, UK) solution at 4 °C. For
the initial 2 passages under the feeder/serum-free conditions
cells were more resistant to dissociation, perhaps because of
carryover of feeder cells, so trypsin was used the dissociate
cultures. Once hES cell cultures were established under the
feeder/serum-free conditions, i.e., they had undergone over
3 passages, cell dissociation solution (CDS)was used instead to
avoid the problem of variability between different batches of
trypsin. Plating efficiency was significantly lower after cells
were dissociated with CDS compared to trypsin (71±5% versus
98±1%, respectively, Pb0.02). Following dissociation, cells
were reseeded at a density of 6×104 cm-2. Cell number was
determined using a hemocytometer and the percentage of
dead cells determined using the trypan blue (Sigma) exclusion
assay. To assess plating efficiency hES cells on feeders were
dissociated with trypsin or CDS and counted before seeding
under feeder/serum-free conditions. After 5 h the numbers of
unattached cells in the medium were counted and subse-
quently the percentage of attached cells was calculated.
In vitro hES cell differentiation
For embryoid body formation hES cells were dissociated using
trypsin/EDTA and cultured for 7 or 13 days in F-DMEM in
bacteriological-grade culture dishes. Day 13 EBs were fixed
for 15 min in 4% paraformaldehye (Sigma). They were then
embedded in gelatin (7.5% gelatin in a 15% sucrose (Sigma)
solution), embedded in O.C.T. embedding compound, frozen
in liquid nitrogen, and sectioned. For extended 2D in vitro
differentiation, Day 7 EBs were plated on glass coverslips
coated with 0.1% gelatin in F-DMEM for a further 14 days.
Immunocytochemistry
For immunostaining cells were fixed in a 4% paraformalde-
hyde solution for 10 min at room temperature. Cultures were
then blocked for 20 min in PBS with 10% serum (of the animal
in which the secondary antibody was raised) in PBS. Cells
were incubated overnight at 4 °C with primary or relevant
isotype control antibodies (Autogen Bioclear, Wiltshire, UK)
in 1% serum in PBS. Primary (and relevant isotype control)
antibody working concentrations were OCT4 2.5 μg/ml,
paxillin 1:200 (BD), Nanog 2 μg/ml, SSEA4 10 μg/ml, SSEA3
10 μg/ml, glial fibrillary acidic protein (GFAP) 5 μg/ml,
brachyury 20 μg/ml, vimentin 5 μg/ml, FOXA2 10 μg/ml,
neurogenin 3 10 μg/ml, FGFR1 1:100 (R&D Systems,
Abingdon, UK), TRA-1-60 10 μg/ml, TRA-1-81 10 μg/ml
(Abcam, Cambridge, UK), pan-specific laminin 1:100, vincu-
lin 1:400 (Sigma), α-fetoprotein (AFP) 1:400 (ICN Biomedi-
cals Inc, Basingstoke, UK), neurofilament 1:500 (Biomol
International, Exeter, UK), αV 10 μg/ml (Calbiochem).
MAB11 and MAB13 (anti-α5 and β1 integrin, respectively)
were the kind gift of Ken Yamada, (NIH). Anti-activated β1
integrin 12G10 was a kind gift from Prof. M Humphries
(Wellcome Matrix Centre, University of Manchester). For
intracellular antigens, 0.1% Triton X-100 (Sigma) was added
throughout the staining procedure. Cells were then incu-
bated for 2 h with 4 μg/ml relevant secondary Alexafluor488
or Alexafluor594-conjugated antibodies (Invitrogen). Cellswere mounted in Vectashield hardset mounting medium with
DAPI (Vector, Peterborough, UK).
Flow cytometry
Single hES cell suspensions were fixed in ice-cold methanol
for 10 min and then permeabilised in a 0.1% Triton X-100
solution for 15 min. Samples were stained with 50 μg/ml
anti-OCT4 or anti-Nanog overnight at 4 °C followed by 1 h
with the appropriate Alexafluor488-conjugated secondary
antibody (4 μg/ml). For controls, cell samples were stained
with secondary antibody only. Flow cytometric analysis was
performed on a Beckman Coulter Cell Lab Quanta SC
machine and at least 20,000 events were collected. The
data were analysed using BC Cell Lab Quanta SC MPL analysis
software.
Reverse-transcriptase PCR
RNA was isolated using TRI reagent (Sigma) according to the
manufacturer's protocol and subsequently treated with
Dnase I (Sigma). RNA was reverse-transcribed using Super-
Script II reverse transcriptase and random primers (Invitro-
gen). PCR was carried out using Biotaq DNA polymerase
(Bioline, London, UK) according to the manufacturer's
protocol. Briefly, samples were denatured for 5 min at
94 °C and then cycled 30 times at 94 °C for 30 s, 50–65 °C for
30 s, and 72 °C for 30 s before a final extension at 72 °C for
10 min. Primers were designed to amplify OCT4, and markers
for endoderm (AFP, SOX17, and GATA4) mesoderm (brachy-
ury, MIXL1, FLK1) and ectoderm (SOX1, nestin, PAX6). β-
Actin and murine GAPDH were amplified as controls. Primer
sequences, annealing temperature, expected size, and gene
accession number are listed in Supplemental Table 1. RT PCR
for the canonical form of CD30 expression was carried out as
published by Herszfeld et al. (2006) using NTERA2 (kind gift
from Professor P. Andrews, University of Sheffield) cDNA as a
positive control.
Karyotyping
hES cells cultured under our feeder/serum-free conditions
for N10 passages were treated with 10 μg/ml colchicine
(Sigma) for 2 h at 37 °C. Cells were then dissociated with
trypsin and treated with hypotonic solution. (27.5% PBS+
solution) for 15 min at 37 °C. Samples were then fixed with
Carnoy's fixative. Cell samples were then G-banded and 24
metaphase spreads were examined for karyotypic abnorm-
alities by TDL, London, UK, and the North West Regional
Cytogenetics Unit.
Adhesion assays
Cells were preincubated with MAB11, MAB13, anti-αV or
appropriate isotype control in culture medium for 30 min at
37 °C. For adhesion assays using GRGDSP peptide and the
GRGQSP control peptide (Bachem, Merseyside, UK) cells
were preincubated with peptide in culture medium for
15 min at 37 °C. Cells were then seeded at a density of 5×104
cm-2 on fibronectin-coated plastic and incubated for a
38 M.A. Baxter et al.further 4 h for antibody assays, or 2.5 h for the peptide assay,
at 37 °C. The percentage adhesion was calculated by
counting the number of unattached cells. Statistical sig-
nificance was assessed using the Student unpaired t test.
Appendix A. Supplementary data
Supplementary data associated with this article can be found,
in the online version, at doi:10.1016/j.scr.2009.03.002.
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